Rifampicin (high-dose formulation for Hi-DoRi-3 therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rifampicin (high-dose formulation for Hi-DoRi-3 therapy), covering 2020-07-24 to 2020-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3) [Phase 3]